Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate
Benaı̈ssa Boubia, Olivia Poupardin, Martine Barth et al. · Journal of Medicinal Chemistry · 2018
Here, we describe the identification and synthesis of novel indole sulfonamide derivatives that activate the three peroxisome proliferator activated receptor (PPAR) isoforms. Starting with a PPARα activator, compound 4, identified during a high throughput screening (HTS) of our proprietary screening library, a systematic optimization led to the discovery of lanifibranor (IVA337) 5, a moderately potent and well balanced pan PPAR agonist with an excellent safety profile. In vitro and in vivo, compound 5 demonstrated strong activity in models that are relevant to nonalcoholic steatohepatitis (NASH) pathophysiology suggesting therapeutic potential for NASH patients.
Cited by 110 works. doi:10.1021/acs.jmedchem.7b01285
Authors
- Benaı̈ssa Boubia
- Olivia Poupardin
- Martine Barth
- Jean L. Binet
- Philippe Peralba
- Elise Jacquier
- Emilie Gauthier
- Valérie Lepais
- Maryline Chatar
- Anne Thourigny
- Fabrice Guillier
- Jonathan Llacer
- Jérôme Amaudrut
- Pierre Dodey
- Olivier Lacombe
- Philippe Masson
- Christian Montalbetti
- Guillaume Wettstein
References
- The PPARs: From Orphan Receptors to Drug Discovery
- Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
- The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors
- PPARδ regulates glucose metabolism and insulin sensitivity
- From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review